Sentences with phrase «g of ethanol»

Not exact matches

Fermentation in the presence of the carboxylate - type liquid zwitterion produced 1.4 g / L ethanol, while no ethanol was obtained with the ionic liquid due to its high toxicity.

With Escherichia coli that can produce ethanol, fermentation ability was examined and revealed to be almost maximal in 0.5 mol / L carboxylate - type liquid zwitterion with a final ethanol concentration of 21 g / L.

In the most conservative countries, low - risk consumption means drinking no more than 10 g of pure ethanol per day for women, 20 g for men.

Rats (150 - 160 g at initiation of feeding protocol) are allowed ad libitum access to the Lieber - DeCarli ethanol diet or pair - fed a control diet, as previously described (1,3).

LPS as 2nd hit: After chronic ethanol feeding, 8 - 10 wk old mice are challenged with 0.7 μg LPS / g body weight or an equivalent volume of sterile, endotoxin - free saline (0.09 %).

A mixture of 3 - methoxybenzaldehyde (50 g, 367.64 mmol) and (2, 4 - dimethylphenyl) hydrazine hydrochloride (63.23 g, 367.64 mmol) in EtOH (50 mL) was stirred at room temperature for 1 h, the obtained solid was filtered off, washed with ethanol and dried under vacuum to afford hydrazone hydrochloride 1 (95.94 g) in 90 % yield as a light brown solid.

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

Briefly, birds were anesthetized with barbiturate anesthetic, equithesin (intrapectorally: 0.85 g chloral hydrate / 4.2 ml pentobarbital / 0.42 g MgSO4 / 6.92 ml propylene glycol / 1.78 ml 100 % ethanol to a total volume of 20 ml with water, then filtered) and secured on a rotary table.

Afterwards, the supernatant was removed by a short spin of the plate bottom up at no more than 9 × g. To wash the pellet, 50 µl of 70 % ethanol was pipetted into each well and again the plate was spun bottom up at no more than 9 × g for 5 — 10 sec.

The three trials compared post-exercise protein synthesis with three different treatments: a post-exercise feeding regimen providing protein intake for optimal muscle protein synthesis [8](2 feedings of 25 g high quality protein at 0 and 4 h of recovery: PRO), a trial in which the subjects consumed 1.5 g · kg − 1 BM ethanol plus an energy match for recommended protein feedings in the form of carbohydrate (ALC - CHO), and ALC - PRO in which the same amount of alcohol was consumed in addition to protein intake in PRO also ingested at 0 and 4 h post-exercise (see Figure 1).

(The wiki values imply densities of 0.72 to 0.74 kg / L for gasoline, 0.762 for Gasohol E10 (10 % ethanol by volume); for 0.73 kg / L and a composition of 84.117 to 85 wt % C (the former calculated for octane, the later given by an encyclopedia (Britannica Macropedia entry «Chemical Elements» p. 945, sorry don't know the year, I'm looking at a photocopy) for petroleum, g CO2 / gal from combustion should be 8517 to 8606.

Based on the just released Low Carbon Fuel Standard prepared by the University of California for the Governor, «regular» gasoline as a value of 85 — 92 g CO2 eq / MJ, while natural gas has a value of ~ 80 g CO2 eq / MJ, electricity in California has an average value of 27 g CO2 eq / MJ (when used to drive an electric vehicle), and cellulosic ethanol derived from municipal solid waste is ~ 5 g CO2 eq / MJ.

While ethanol, for example derived from corn but distilled in a facility powered by coal was, in fact, on average worse, than gasoline, some of the envisioned cellulosic - based biofuels could be dramatically better on a g CO2 eq / MJ basis.

Ethanol production is often tied to factory farming G of livestock.